WB
TEVA icon

WesBanco Bank’s Teva Pharmaceuticals TEVA Stock Holding History

WesBanco Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,576
Closed -$203K – 531
2016
Q4 		$203K Sell
5,576
-955
-15% -$38.1K 0.01% 476
2016
Q3 		$300K Sell
6,531
-650
-9% -$33.9K 0.02% 397
2016
Q2 		$360K Sell
7,181
-168
-2% -$8.94K 0.02% 377
2016
Q1 		$393K Buy
7,349
+805
+12% +$47.2K 0.02% 347
2015
Q4 		$430K Buy
6,544
+560
+9% +$34.6K 0.03% 331
2015
Q3 		$338K Hold
5,984
– – 0.02% 367
2015
Q2 		$354K Sell
5,984
-1,565
-21% -$96.5K 0.02% 381
2015
Q1 		$471K Sell
7,549
-2,155
-22% -$125K 0.03% 342
2014
Q4 		$558K Sell
9,704
-1,380
-12% -$76.9K 0.03% 316
2014
Q3 		$596K Sell
11,084
-990
-8% -$52.4K 0.03% 314
2014
Q2 		$633K Hold
12,074
– – 0.04% 305
2014
Q1 		$638K Buy
12,074
+3,153
+35% +$146K 0.04% 308
2013
Q4 		$358K Sell
8,921
-3,850
-30% -$152K 0.02% 387
2013
Q3 		$482K Sell
12,771
-293
-2% -$11.4K 0.03% 331
2013
Q2 		$512K Buy
+13,064
New +$509K 0.03% 312

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WesBanco Bank's TEVA Position: Q1 2017 in Review

WesBanco Bank sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 5,576 shares — an estimated $203K sold.

WesBanco Bank first reported a position in TEVA in Q2 2013 and held it in 15 quarters. The position peaked at $638K in Q1 2014. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • WesBanco Bank reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • WesBanco Bank sold 5,576 Teva Pharmaceuticals shares in Q1 2017, an estimated $203K.
  • WesBanco Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • WesBanco Bank's Teva Pharmaceuticals position peaked at $638K in Q1 2014.
  • 686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on WesBanco Bank's 13F filing for Q1 2017, filed 27 Apr 2017.